Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Mallinckrodt
Baxter
Covington
Fuji
Deloitte

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 6,316,612

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,316,612
Title: Xylofuranosly-containing nucleoside phosphoramidites and polynucleotides
Abstract:Novel xylo nucleoside or xylo nucleotide analogs, polynucleotides comprising xylo nucleotide substitution, processes for their synthesis and incorporation into polynucleotides.
Inventor(s): Matulic-Adamic; Jasenka (Boulder, CO), Beigelman; Leonid (Longmont, CO)
Assignee: Ribozyme Pharmaceuticals, Inc. (Boulder, CO)
Application Number:09/135,964
Patent Claims:see list of patent claims

Details for Patent 6,316,612

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2017-08-22 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2017-08-22 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up Ribozyme Pharmaceuticals, Inc. (Boulder, CO) 2017-08-22 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

International Patent Family for US Patent 6,316,612

Country Patent Number Publication Date
United States of America 2001006801 Jul 05, 2001
United States of America 2002013458 Jan 31, 2002
United States of America 2002082225 Jun 27, 2002
United States of America 2002192685 Dec 19, 2002
United States of America 2002193579 Dec 19, 2002
United States of America 2002197684 Dec 26, 2002
United States of America 2003003469 Jan 02, 2003
>Country >Patent Number >Publication Date

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Harvard Business School
QuintilesIMS
AstraZeneca
Baxter
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.